HOME >> MEDICINE >> NEWS
UCSF study offers insight into human circadian rhythms

The scientists do not know what accounts for the difference.

"The findings suggest that, although many individual parts of the circadian rhythm clock are conserved across species, fundamental differences exist," says the first author of the study, Ying Xu, PhD, a visiting postdoctoral fellow in the Fu lab. "These models provide the opportunity to begin study of the similarities and differences between circadian clocks in model organisms and humans."

While the internal clock of most people operates in just over a 24-hour time period, the clock of those with FASPS advances an average of 45 minutes a day. If left unchecked, it would continue to speed up. Due to the social demands and needs of those with the disorder, it is kept in check to a relative degree.

The creation of the transgenic mouse model provides a tool for exploring how the CK1 delta-T44A enzyme causes FASPS. It also offers a model for testing promising compounds directed at the enzyme to treat a variety of sleep disorders, whether resulting from biological or environmental factors.

While FASPS is caused by an individual gene, other forms of sleep-pattern disturbances, such as the tendency for some elderly to wake up earlier than normal ("advanced sleep phase syndrome"), could be caused by "epigenetic" factors, which involve changes in gene expression rather than a mutation in a gene.

Finally, the potential insights extend beyond those involving sleep. Four of the five individuals in the study have clinical features or a history of depression. While the scientists say that this could be a coincidence, or that the depression is situational, i.e., due to being "out of phase with the rest of the world," the more provocative possibility, they say, is that circadian rhythm variants contribute to psychiatric disorders.

Now, in collaboration with UCSF's Larry Tecott, MD, PhD, UCSF associate professor of psychiatry and a member of the UCSF Center for Neurobiology an
'"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
30-Mar-2005


Page: 1 2 3 4

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. International breast cancer prevention study launches in the United States and Canada
7. UW study shows blacks and Latinos are more satisfied with physicians of the same race
8. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
9. Advertising by academic medical centers may risk eroding public trust, says study
10. Fat may promote inflammation, new study suggests
11. Bullying among sixth graders a daily occurrence, UCLA study finds

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCSF study offers insight into human circadian rhythms

(Date:5/22/2013)... 2013 In partnership with the ... LLC, E-Dentists.com has launched a new SEO blog ... numerous topics of interest to dentists and their ... health. , http://www.E-Dentists.com/Blog/ , Blogging has ... In addition to addressing keyword placement and link ...
(Date:5/22/2013)... Women,s Hospital (BWH) finds that a genetic risk factor ... may be effective in identifying individuals at risk for ... the American Thoracic Society International Conference and publish online ... on May 22 and will appear in the ... the MUC5B gene is fairly common, pulmonary fibrosis is ...
(Date:5/22/2013)... 21 May 2013, Paris, France: Results from ... 2013 today question whether bivalirudin is superior ... blockade, showing similar 30-day mortality in patients ... (NSTE-ACS) undergoing percutaneous coronary intervention (PCI)., European ... alone as an alternative to unfractionated heparin ...
(Date:5/22/2013)... CO and Purchase, NY (PRWEB) May 22, 2013 ... has formed an exclusive partnership with Aurora ... an innovative marketing tool to companies that offer ... health card rewards members for completing 3 out ... The healthcare incentive product launched March 2013, and ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 In the ... the country’s fields and courts with donated uniforms, ... a Massachusetts-based nonprofit dedicated to partnering with manufacturers to ... celebrating the donation of $8.8 million in sports and ... than a half-million kids outfitted for physical activity. ...
Breaking Medicine News(10 mins):Health News:Dental SEO Blog Launched by E-Dentists.com in Partnership with JD Media Surge, LLC 2Health News:Genetic marker associated with risk for pulmonary fibrosis 2Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Integrated Printing Solutions and Aurora Financial Systems, Inc. Create Partnership for Healthcare Incentive Card 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3
(Date:5/22/2013)... and TORONTO , May 22, 2013 /PRNewswire/ ... John Mon , Chief Operating Officer, will ... Thursday, May 30, 2013 in New York City ... The Company,s presentation is scheduled to begin at 4:00 p.m. ... access the webcast, go to:   http://wsw.com/webcast/marcum/mfs.v/   ...
(Date:5/22/2013)... May 22, 2013  BD (Becton, Dickinson and Company) ... technology company, announced today the publication of its ... Report and it continues to focus on the Company,s ... believe the principles of shared value — creating value ... of societies — are fundamental to our strategy," said ...
(Date:5/22/2013)... , May 22, 2013 Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for its Phase ... TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular ... date the trial has had no Severe Adverse Effect (SAE) ... therapy for HCC, registered with NIH under number NCT01828762 ...
Breaking Medicine Technology:Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 2Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 3
Cached News: